Kageaki Watanabe

605 citations
47 papers · 406 indexed · h-index 10
Topics
Lung Cancer Treatments and Mutations (32 papers)Lung Cancer Research Studies (20 papers)Colorectal Cancer Treatments and Studies (10 papers)

In The Last Decade

Kageaki Watanabe

43 papers receiving 400 citations

Peers

Kageaki Watanabe
Comparison fields: 5 of 53
  • Oncology 288
  • Pulmonary and Respiratory Medicine 211
  • Immunology 65
  • Molecular Biology 52
  • Neurology 43
Replace Yaobin Lin with:
Yaobin Lin China
Christiane Jungels Belgium
Gustavo Schvartsman Brazil
Hyeong Chan Shin South Korea
Birthe Heitkötter Germany
Xiaoliang Zhao China
Noelia Vilariño Spain
Yuichi Ando Japan
Rania Chehade Canada
Tomoyuki Igarashi Japan
Kageaki Watanabe relative to Yaobin Lin China Yaobin Lin's profile →
Citations per field
00.5×4.1×
Yaobin Lin · 1×
Citations per year

Countries citing papers authored by Kageaki Watanabe

Since Specialization
Citations

This map shows the geographic impact of Kageaki Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kageaki Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kageaki Watanabe more than expected).

Fields of papers citing papers by Kageaki Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kageaki Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kageaki Watanabe. The network helps show where Kageaki Watanabe may publish in the future.

Co-authorship network of co-authors of Kageaki Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Kageaki Watanabe. A scholar is included among the top collaborators of Kageaki Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kageaki Watanabe. Kageaki Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 1
4 0
5 1
6 1
7 2
8 5
9 4
10 7
11 9
12 1
13 5
14 10
15 3
16 1
17 1
18 8
19 2
20 0

About Kageaki Watanabe

Kageaki Watanabe is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Neurology, having authored 47 papers that have together received 406 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (20 papers) and Colorectal Cancer Treatments and Studies (10 papers). The work is most often cited by research in Oncology (288 citations), Pulmonary and Respiratory Medicine (211 citations) and Immunology (65 citations). Kageaki Watanabe has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yukio Hosomi, Yusuke Okuma, Sadamu Homma, Yoshiro Nakahara, Yukiko Sagawa, Makiko Yomota, Tatsuru Okamura, Tsunekazu Hishima, Yasuhiro Kato and Taiki Hakozaki. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026